Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-26 Sale | 2024-09-30 4:15 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 2,542 | $49.03 | $124,634 | 27,630 (Direct) | View |
| 2024-03-05 Sale | 2024-03-05 4:18 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 672 | $32.57 | $21,887 | 95,840 (Direct) | View |
| 2024-01-24 Sale | 2024-01-24 4:23 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 1,886 | $21.64 | $40,813 | 13,069 (Direct) | View |
| 2023-09-28 Sale | 2023-09-28 4:02 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 2,179 | $24.79 | $54,017 | 24,520 (Direct) | View |
| 2023-06-30 Sale | 2023-06-30 4:03 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 1,597 | $28.36 | $45,291 | 9,163 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-26 Exercise | 2024-09-30 4:15 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 7,473 | $0 | 27,630 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 4:18 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 77,000 | $0 | 95,840 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 4:18 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 2,000 | $0 | 95,840 (Direct) | View |
| 2024-01-20 Exercise | 2024-01-24 4:23 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 5,380 | $0 | 13,069 (Direct) | View |
| 2023-09-26 Exercise | 2023-09-28 4:02 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 7,472 | $0 | 24,520 (Direct) | View |
| 2023-06-28 Exercise | 2023-06-30 4:03 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 5,380 | $0 | 9,163 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:07 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 28,000 | $0 | 28,000 (Direct) | View |
| 2022-09-26 Option Award | 2022-09-28 4:10 pm | N/A 2032-09-26 | AGIOS PHARMACEUTICALS INC. | AGIO | Jones Cecilia Chief Financial Officer | 140,807 | $0 | 140,807 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:05 pm | N/A 2032-03-01 | LogicBio Therapeutics Inc. | LOGC | Jones Cecilia Chief Financial Officer | 112,000 | $0 | 112,000 (Direct) | View |
| 2022-01-12 Tax Withholding | 2022-01-13 6:36 pm | N/A N/A | LogicBio Therapeutics Inc. | LOGC | Jones Cecilia Chief Financial Officer | 2,175 | $2.01 | 3,764 (Direct) | View |
| 2022-01-11 Exercise | 2022-01-13 6:36 pm | N/A N/A | LogicBio Therapeutics Inc. | LOGC | Jones Cecilia Chief Financial Officer | 5,939 | $0 | 3,764 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 7:00 pm | N/A 2031-02-23 | LogicBio Therapeutics Inc. | LOGC | Jones Cecilia Chief Financial Officer | 78,000 | $0 | 78,000 (Direct) | View |
| 2021-01-11 Option Award | 2021-01-13 7:10 pm | N/A 2031-01-11 | LogicBio Therapeutics Inc. | LOGC | Jones Cecilia Chief Financial Officer | 200,939 | $0 | 200,939 (Direct) | View |